Is ABBV Worth Buying in 2026?

ABBVIE INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether ABBVIE INC. (ABBV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.53% over 10 days); strong 1-year return of +21.2%. Concerns: RSI 72 — overbought, elevated pullback risk. Currently 7.2% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

ABBV is in a confirmed uptrend, trading above both its 50-day ($209.61) and 200-day ($219.95) moving averages. With an RSI of 72.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +21.2% compares to +24.4% for SPY (trailed the market by 3.2%).

$10,000 invested 1 year ago → $12,121 today
vs. S&P 500 (SPY) — same period trailed market by 3.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($219.95)
Above 50-day MA ($209.61)
!RSI(14) neutral zone (30–70) — currently 72.0
Positive return (+21.2%)
Within 10% of period high (−7.2%)
Period Range $227.23
$181.73 $244.81
RSI (14) 72.0
0 · OversoldOverbought · 100

Key Metrics

Price$227.23
Period Return+21.2%
Period High$244.81
Period Low$181.73
Drawdown−7.2%
MA-50$209.61
MA-200$219.95
RSI (14)72.0
Avg Volume (30d)6.1M
vs. SPYtrailed by 3.2%
Return Rank#536 of 1245

Trade ABBV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers